Back to Stakeholders
Government, Policy & AdvocacyPolicy Advocacy & ReformDrug Policy Reform Organizations
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchCollaborative Research Consortia
Government, Policy & AdvocacyPolicy Advocacy & Reform
Government, Policy & Advocacy
Research, Drug Development & Manufacturing

Swiss Medical Society for Psycholytic Therapy

Switzerland

Swiss medical society founded in 1985 whose members received special permission from the Swiss Federal Office of Public Health to conduct psychedelic-assisted therapy with MDMA and LSD in private practices from 1988 to 1993, treating approximately 170 patients. SÄPT continues to advance psycholytic therapy through research, training, and individual treatment licenses, and sponsored the LSD-Assist Study demonstrating persistent anxiety reductions at two-year follow-up.

Academic Research

0 papers

Published Papers

0

Trial Involvement

0

Distinct Focus Topics

0

Latest Publication

Unknown

Entity type: Research Consortium / Network

Network Scope

Membership society model linking practitioner and research communities in Switzerland.

Collaboration Notes

Professional society network coordinating clinicians and researchers in psycholytic-assisted treatment contexts.

Collaboration Info

Quick Facts

Type
Non-Profit
HQ
Switzerland
Website
Visit